C3 Cannabinoid Compound

Curated by Signal

Manufacturer and distributor of cannabis-derived pharmaceutical products

Overview

Manufacturer and distributor of cannabis-derived pharmaceutical products. The company focuses on the research and development of key therapeutic ingredients of the cannabis flower such as tetrahydrocannabinol and cannabidiol. The first product of the company is "Dronabinol" for nausea, vomiting, cancer, and palliative care.

Key facts

Headquarters: Germany
Stage: Sign up to view
Industry: Health Technology

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

INDAMED
Provider of practice management software and services for healthcare providers
Health TechnologySchwerin, Germany
Tomorrow Bio
Provider of a platform for patients for body preservation
Health TechnologyBerlin, Germany
EcoCare
Provider of health tests kits and products
Health TechnologyDusseldorf, Germany

About C3 Cannabinoid Compound

What does C3 Cannabinoid Compound do?

Manufacturer and distributor of cannabis-derived pharmaceutical products.

Where is C3 Cannabinoid Compound headquartered?

C3 Cannabinoid Compound is headquartered in Germany.

Which sector is C3 Cannabinoid Compound in?

C3 Cannabinoid Compound operates in Health Technology.

Who are C3 Cannabinoid Compound's competitors?

Companies similar to C3 Cannabinoid Compound include INDAMED, Tomorrow Bio, and EcoCare.